title: Extreme bradycardia due to multiple drug-drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir-ritonavir.
authors.forename: Rachel
authors.initials: R
authors.lastname: Puech
authors.forename: Marie-Claude
authors.initials: MC
authors.lastname: Gagnieu
authors.forename: Caroline
authors.initials: C
authors.lastname: Planus
authors.forename: Bruno
authors.initials: B
authors.lastname: Charpiat
authors.forename: André
authors.initials: A
authors.lastname: Boibieux
authors.forename: Tristan
authors.initials: T
authors.lastname: Ferry
authors.forename: Michel
authors.initials: M
authors.lastname: Tod
mesh_terms: D001919:Bradycardia / Q000139:chemically induced*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D056990:Post-Exposure Prophylaxis; D011744:Pyrimidinones / Q000009:adverse effects*; D019438:Ritonavir / Q000009:adverse effects*
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir